Acadia Pharma (ACAD) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $30.18 +4.03%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q2 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Halozyme adds biotech executive Appelhans to its board
- La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
